Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    VHH and the blood–brain barrier challenge
    1 April 2026

    Crossing the blood–brain barrier: Why VHHs matter for CNS Biologics

    The blood–brain barrier (BBB) remains one of the hardest challenges in biologics development. Designed to protect the central nervous system, it tightly controls which molecules can enter the brain — but this same selectivity prevents many promising therapeutic formats, including antibo...

    Lipid Nanoparticles for Drug Delivery
    2 March 2026

    Beyond liver uptake: How VHHs could support more targeted LNP delivery

    Lipid nanoparticles have become one of the most important delivery platforms for next-generation therapeutics, particularly for payloads such as mRNA, siRNA and oligonucleotides. But many programmes still face a major challenge: how to move beyond liver-dominant uptake and achieve more ...

    It’s time to govern your team’s AI use
    28 April 2026

    It’s time to govern your team’s AI use

    Do you know which AI tools your team is using at work… and what they’re putting into them?Most senior leaders we speak to think they do. Until we dig a little deeper.Generative AI tools like ChatGPT and Gemini have slipped into everyday work incredibly fast. They’re great for produ...

    Bio-Rad logo
    28 April 2026

    Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers

    New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma LaboratoriesHERCULES, Calif.—April 28, 2026—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, an...

    When Hits Don’t Translate
    10 April 2026

    Webinar: When Hits Don’t Translate – Challenging Membrane Targets from GPCRs to CD3–TCR

    How target presentation and environment shape epitope access, selection outcomes, and functional screening. ...

    Steve Harvey, CEO, Camena
    28 April 2026

    First letting secured at Sidney Sussex Building, Chesterford Research Park

    Cambridge, UK, 28th April 2026: 

    rom dispersed inputs to integrated outcomes: where decision confidence is formed may matter more than where deals are signed.
    28 April 2026

    From licensing to integration: is decision-making in life sciences moving upstream?

    Recent cross-border licensing activity involving China-origin biopharmaceutical assets suggests a subtle but important shift in how global partnerships are being structured. While attention often focuses on total deal value, the more meaningful signal may lie in the underlying terms. ...

    BioResource Scientific Conference 2026 photo
    20 April 2026

    BioResource scientific conference returns for 2026

    Join us for the fourth edition of the NIHR BioResource Scientific Conference on Wednesday 17th June. ...

    Martin Stapleton, Chairman, PlaqueTec
    27 April 2026

    PlaqueTec closes $5 million financing

    Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmesCambridge, UK, 27 April 2026: PlaqueTec, a medtech company pioneering intracorona...

    Guardtech Cleanrooms
    24 April 2026

    Build your next big, bold and beautiful controlled environment facility with Cleanroom Solutions

    Guardtech’s turnkey brand are redefining high-spec cleanroom construction by marrying operational excellence and environmental efficiency with new installation innovation and stunning aesthetics ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 19
    • Page 20
    • Current page 21
    • Page 22
    • Page 23
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS